| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |